
Decitabine - Oncological Agent For Myelodysplastic Syndromes Treatment | Interferes With Cancer Cell Growth And Spread
Price:
Get Latest Price
In Stock
Product Specifications
Dosage | 50mg |
Form | Lyophilized powder |
Route | Intravenous |
Packaging | Single dose vial |
Material | Glass vial |
Storage | Refrigerated |
Expiry | Specified on label |
Features | Cancer treatment, Bone marrow cancer, IV administration, Single dose vial, Effective treatment, Improved survival, Easy to use |
Payment Terms | Western Union, Paypal, Others, Telegraphic Transfer (T/T) |
Delivery Time | 1 Week |
Sample Policy | Contact us for information regarding our sample policy |
Main Export Market(s) | Australia, Central America, Western Europe, Middle East, Africa, South America, Asia, Eastern Europe, North America |
Main Domestic Market | All India |
Product Overview
Key Features
Company Details
Established in 1991 in Hyderabad, India, Vivimed Labs has metamorphosed from a domestic small, entrepreneurial family-operated business to a globally renowned supplier of niche molecules and formulations across Healthcare, Pharmaceuticals and Specialty Chemicals consumers in nearly 50 countries.
Business Type
Exporter, Manufacturer, Distributor, Supplier, Wholesaler, Retailer, Dealer
Employee Count
73422
Establishment
1956
Working Days
Monday To Sunday
GST NO
37AAACV6060A1ZO
Related Products
More Product From This seller
Seller Details
GST - 37AAACV6060A1ZO
Hyderabad, Telangana
Mr Andrew G Hall
Address
Vivimed Labs Ltd. North End, Road No.2, Banjara Hills, Hyderabad, Telangana, 500034, India
decitabine in Hyderabad
Report incorrect details